ArticleInternal medicine (Tokyo, Japan)2020

SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology.

Norio Akuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.